Thus, introduction of “immunoscore” based on the levels of CD3+ and CD45RO+, CD3+ and CD8+, or CD8+ and CD45RO+ in the core tumor (CT) and at the invasive margin (IM) by Galon et al., showed superior prognostic ability in CRC patients [25]. Here, CD8A is linked to neoplasm.